Autonomix Medical Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Cash & Equivalents	7	9.14	8.61	0.87
Cash & Short-Term Investments	7	9.14	8.61	0.87
Cash Growth	-23.34%	6.13%	895.14%	-
Other Current Assets	0.58	0.47	0.78	-
Total Current Assets	7.58	9.61	9.39	0.87
Net Property, Plant & Equipment	0.02	0.02	0.02	-
Total Assets	7.6	9.81	9.41	0.87
Accounts Payable	0.7	0.68	0.49	0.17
Accrued Expenses	1.01	1.03	0.29	0.05
Total Current Liabilities	1.71	1.71	0.78	0.22
Long-Term Debt	-	-	1	-
Total Long-Term Liabilities	-	-	1	-
Total Liabilities	1.71	1.71	1.78	0.22
Common Stock	-	-	0	0.01
Additional Paid-in Capital	-	-	46.6	24.18
Retained Earnings	-	-	-38.97	-23.54
Shareholders' Equity	-	-	7.63	0.64
Total Liabilities & Equity	7.6	9.81	9.41	0.87
Total Debt	0	0	1	0
Net Cash (Debt)	7	9.14	7.61	0.87
Net Cash Growth	-23.34%	20.12%	779.31%	-
Net Cash Per Share	20.38	108.61	153.48	30.22
Book Value	0	0	7.63	0.64
Book Value Per Share	-	-	153.92	22.50
Tangible Book Value	0	0	7.63	0.64
Tangible Book Value Per Share	-	-	153.92	22.50

SEC Filings: 10-K · 10-Q